1 / 27

Klinisk strålebiologi - normalvev

Klinisk strålebiologi - normalvev. Tidlig reaksjon. Sen reaksjon. teleangiectasi. Basis for dose-respons-kurver. Stigetallet for dose-responskurven. Gaussian distribution of radiation sensitivity. Gaussian distribution of technical and dosimetrical factors.

Download Presentation

Klinisk strålebiologi - normalvev

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Klinisk strålebiologi - normalvev

  2. Tidlig reaksjon

  3. Sen reaksjon teleangiectasi

  4. Basis for dose-respons-kurver

  5. Stigetallet for dose-responskurven

  6. Gaussian distribution of radiation sensitivity Gaussian distribution of technical and dosimetrical factors Uniquely described by two parameters: - gradient at 50% response level D50% - dose to achieve 50% response biolo > clin Dose response curve Clinical dose response curve Pettersen M et al Radiotherapy and Oncology 2008

  7. Uniquely described by two parameters: - gradient at 50% response level D50% - dose to achieve 50% response   is linked to the standard deviation, , of the Gaussian distribution by:  and Pettersen M et al Radiotherapy and Oncology 2008

  8. Steepness of clinical dose-response curve is depending of the dose variation Pettersen M et al Radiotherapy and Oncology 2008 Roué et al 2004 ESTRO-Equal external audit 102 centres, 235 beams in France 3% beams had deviations >  5% 24 centres had deviations >  5%

  9. Design of a randomised clinical study • The null hypothesis is that the two treatment options produce no different outcome • To prove a difference, the null hypothesis has to be rejected • The numberof patients needed is linked to , the difference in response (R), the level of significance () and the power ()  = 0.2  = 0.05 Pettersen M et al Radiotherapy and Oncology 2008

  10. The number of patients required Conclusions: To keep the number of patients required for RCT as low as possible, the standard deviation of the dosimetry should be kept below 5%.

  11. Volumeffet for rektumblødning

  12. Strandqvist plot

  13. a-kill b-kill LQ-formelverket

More Related